IGF‐1 then binds to its IGF‐1R, activating key oncogenic pathways such as PI3K/AKT/mTOR and MAPK/ERK, which drive cell proliferation, survival, and metabolic adaptation in cancer cells. Here, MTOR is linked to cancer.